Claus Roehrborn

About

Claus Roehrborn is a leading urologist whose research has fundamentally advanced the surgical treatment of benign prostatic hyperplasia (BPH), particularly for patients with large prostate glands. His work focuses on comparing and validating minimally invasive and robotic surgical techniques against traditional open procedures. A major contribution is his landmark 2017 study (93 citations) comparing robot-assisted versus open simple prostatectomy, providing the largest comparative analysis at the time and demonstrating the superior perioperative outcomes of the robotic approach. Roehrborn has also been instrumental in evaluating Aquablation therapy, a novel water-jet ablation technique. His 2023 publication (49 citations) reports the final five-year results of the WATER II clinical trial, establishing the long-term safety and efficacy of Aquablation for prostates between 80-150 mL. Through these high-impact studies, Roehrborn has provided crucial evidence that shapes clinical guidelines, offering patients less invasive options with reduced recovery times. His work continues to define the standard of care for surgical management of BPH.

Research Focus

Key Achievements

Top Papers

1. 1
   Robot-Assisted Versus Open Simple Prostatectomy for Benign Prostatic Hyperplasia in Large Glands: A Propensity Score–Matched Comparison of Perioperative and Short-Term Outcomes

   93 citations · 2017
2. 2
   Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results

   49 citations · 2023
3. 3
   PD6-12 SINGLE VERSUS DUAL CONSOLE ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY: IMPACT ON INTRAOPERATIVE AND POSTOPERATIVE OUTCOMES

   2 citations · 2014
4. 4
   What’s New in Aquablation

   2 citations · 2018

Key Collaborators

Contact & Links